tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:78Q Stock Latest News

Philogen Expands Treasury Stock as Biotech Buyback Program Advances
Company AnnouncementsPhilogen Expands Treasury Stock as Biotech Buyback Program Advances
13d ago
Spouse of Philogen Chairman Sells 800 Shares in Insider Transaction Disclosure
PremiumCompany Announcements
Spouse of Philogen Chairman Sells 800 Shares in Insider Transaction Disclosure
16d ago
Philogen Increases Treasury Stock with New Tranche of Share Buybacks
PremiumCompany Announcements
Philogen Increases Treasury Stock with New Tranche of Share Buybacks
19d ago
Philogen Advances Early RA Trial With F8IL10, Signaling Continued Pipeline Progress
PremiumCompany Announcements
Philogen Advances Early RA Trial With F8IL10, Signaling Continued Pipeline Progress
1M ago
78Q
Philogen Completes Early Trial of New Prostate Cancer Imaging Agent: What Investors Should Watch
PremiumCompany Announcements
Philogen Completes Early Trial of New Prostate Cancer Imaging Agent: What Investors Should Watch
2M ago
78Q
Philogen’s New Phase 2 Study: A Potential Game-Changer in Skin Cancer Treatment
PremiumCompany AnnouncementsPhilogen’s New Phase 2 Study: A Potential Game-Changer in Skin Cancer Treatment
2M ago
78Q
Philogen’s New Phase 2 Study: A Potential Game-Changer in Basal Cell Carcinoma Treatment
Premium
Company Announcements
Philogen’s New Phase 2 Study: A Potential Game-Changer in Basal Cell Carcinoma Treatment
2M ago
78Q
Philogen Updates on Share Buyback Program
Premium
Company Announcements
Philogen Updates on Share Buyback Program
2M ago
Philogen S.p.A. Reports Strong Financial Position and Advances in Clinical Trials
PremiumCompany Announcements
Philogen S.p.A. Reports Strong Financial Position and Advances in Clinical Trials
3M ago
Philogen S.p.A. Updates Share Buyback Program
PremiumCompany Announcements
Philogen S.p.A. Updates Share Buyback Program
4M ago
Philogen S.p.A. Updates on Share Buyback Program
PremiumCompany Announcements
Philogen S.p.A. Updates on Share Buyback Program
5M ago
Philogen Updates on Share Buyback Program
PremiumCompany Announcements
Philogen Updates on Share Buyback Program
5M ago
Philogen Reports Strong Revenue Growth and Advances in Clinical Pipeline
PremiumCompany AnnouncementsPhilogen Reports Strong Revenue Growth and Advances in Clinical Pipeline
5M ago
Philogen S.p.A. Updates on Share Buyback Program
Premium
Company Announcements
Philogen S.p.A. Updates on Share Buyback Program
5M ago
Philogen Finalizes $1.35 Billion OncoACP3 License Agreement with RayzeBio
Premium
Company Announcements
Philogen Finalizes $1.35 Billion OncoACP3 License Agreement with RayzeBio
6M ago
Philogen Updates Share Buyback Program with Recent Purchases
PremiumCompany Announcements
Philogen Updates Share Buyback Program with Recent Purchases
8M ago
Philogen Updates Share Buyback Program with Recent Purchases
PremiumCompany Announcements
Philogen Updates Share Buyback Program with Recent Purchases
8M ago
Philogen Withdraws Nidlegy™ Application from EMA, Plans Resubmission
PremiumCompany Announcements
Philogen Withdraws Nidlegy™ Application from EMA, Plans Resubmission
8M ago
Philochem Licenses Prostate Cancer Agent to RayzeBio in $1.35 Billion Deal
PremiumCompany Announcements
Philochem Licenses Prostate Cancer Agent to RayzeBio in $1.35 Billion Deal
9M ago
Philogen Updates on Share Buyback Program
PremiumCompany AnnouncementsPhilogen Updates on Share Buyback Program
9M ago
Philogen S.p.A. Releases Shareholders’ Meeting Minutes
Premium
Company Announcements
Philogen S.p.A. Releases Shareholders’ Meeting Minutes
9M ago
Philogen S.p.A. Updates on Share Buyback Program
Premium
Company Announcements
Philogen S.p.A. Updates on Share Buyback Program
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >